Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C

Interferon is used to treat hepatitis C virus infection and its cutaneous side effects are well known. Recently, interferon-induced sarcoidosis has been reported. We report a new case of sarcoidosis during pegylated interferon alfa and ribavirin treatment with an unusual presentation in a woman with...

Full description

Saved in:
Bibliographic Details
Main Authors: R. Rodríguez-Lojo (Author), M. Almagro (Author), J. M. Barja (Author), F. Piñeyro (Author), L. Pérez-Varela (Author), J. Del Pozo (Author), M. T. Yebra-Pimentel (Author), E. Fonseca (Author)
Format: Book
Published: Hindawi Limited, 2010-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Interferon is used to treat hepatitis C virus infection and its cutaneous side effects are well known. Recently, interferon-induced sarcoidosis has been reported. We report a new case of sarcoidosis during pegylated interferon alfa and ribavirin treatment with an unusual presentation in a woman with previous episodes of erythema nodusum and nodular vasculitis related to HCV.
Item Description:1687-6105
1687-6113
10.1155/2010/230417